Monitoring of anticoagulation in extracorporeal membrane oxygenation: is anti-Xa the new activated clotting time?
Pediatr Crit Care Med
.
2015 Jan;16(1):87-9.
doi: 10.1097/PCC.0000000000000298.
Authors
Laurance Lequier
1
,
M Patricia Massicotte
Affiliation
1
Department of Pediatrics Stollery Children's Hospital University of Alberta Edmonton, AB, Canada.
PMID:
25560288
DOI:
10.1097/PCC.0000000000000298
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / therapeutic use*
Extracorporeal Membrane Oxygenation / adverse effects*
Female
Hemorrhage / etiology*
Humans
Male
Substances
Anticoagulants